Table 1.
Unit costs for healthcare resources in Euros (year 2009 values).
Figure 1.
Flow-chart of the study.
Table 2.
Socio-demographic and clinical baseline characteristics of the sample.
Table 3.
Multiple imputed and pooled costs after 6 months follow-up in the usual care and interventioun groups and mean differences between groups (95% CI) (unadjusted analysis).
Table 4.
Mean pooled differences in total effects and costs at 6 months follow-up and results of cost-effectiveness and cost-utility analyses after 6 months follow-up for the main analysis and for the sensitivity analyses.
Figure 2.
Cost-effectiveness plane for adherence with antidepressant therapy (pharmacist intervention vs usual care) and cost-effectiveness acceptability curves for adherence with antidepressant therapy, remission of depressive symptoms (PHQ-9) and QALYs estimated using bootstrapping from the societal perspective.
The central white dot in the cost-effectiveness plane indicates the point estimate of the incremental cost-effectiveness ratio.